CardieX Limited (ASX: CDX), a Sydney, Australia- and Naperville, IL-based well being know-how firm, acquired Blumio, a Silicon Valley based mostly developer of algorithms and know-how for cardiovascular sensors.
The quantity of the deal was not disclosed.
With the acquisition, CardieX will improve medical efficiency for its ecosystem of coronary heart well being monitoring options. Blumio has additionally developed a set of knowledge analytics and visualization instruments used to uncover insights in medical knowledge that contribute to CardieX’s present wearable growth efforts. These instruments will improve CardieX’s “Arty™ Heart Health Analytics Platform” to proactively monitor, alert, and supply actionable well being insights from CardieX’s CONNEQT Pulse and CONNEQT Band units – thereby enabling physicians and sufferers alike to make extra knowledgeable healthcare selections.
Led by CEO Catherine Liao, Blumio is a sensor know-how startup centered on creating wearable sensors and cardiovascular well being algorithms, together with blood stress estimation that isn’t reliant on an inflatable cuff. Its radio frequency know-how gathers a validated pulse stress waveform that allows at-home, all-day, and all-night cardiovascular well being knowledge assortment to assist physicians and sufferers make knowledgeable healthcare selections associated to varied well being issues, from hypertension to maternal well being.
Led by CEO Craig Cooper, CardieX is a well being know-how firm that focuses on hypertension, heart problems, and different arterial well being issues. Its ATCOR division is targeted on medical units for measuring arterial stiffness and central blood stress waveforms based mostly on its distinctive FDA-cleared and patented SphygmoCor know-how. Under the CONNEQT model, the corporate develops wearables, digital options, and units for distant affected person monitoring, decentralized medical trials, and residential well being. CardieX is listed on the Australian Stock Exchange (ASX:CDX).